Search Results
Aug 18, 2026, 21:00 ET Antengene Presents Key R&D Highlights at the Evercore 2nd China Biotech Summit
CD3 (ATG-107 for acute myeloid leukemia).To date, Antengene has obtained 33 investigational new drug (IND) approvals in the U.S. and Asia, and obtained new drug application (NDA) approvals in 10 Asia Pacific markets. Its lead commercial asset, XPOVIO® (selinexor), is approved in
More news about: Antengene Corporation Limited
Aug 18, 2026, 20:15 ET CARsgen Therapeutics Announces 2026 Interim Results
proteasome inhibitor and an immunomodulatory agent) in 2024. In December 2025, zevor-cel was included in China's Commercial Health Insurance Innovative Drug Catalogue (2025).CARsgen entered into a collaboration agreement with Huadong Medicine (000963.SZ) for the commercialization of
More news about: CARsgen Therapeutics
Aug 18, 2026, 19:54 ET MDLN Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm
the Reuters article states that according to the FDA, Medline "failed to thoroughly investigate microbial contamination incidents in finished drug products and also cited inadequate cleaning practices."Why Did Medline's Stock Drop?Following the news of Medline's FDA
More news about: Kessler Topaz Meltzer & Check, LLP
Aug 18, 2026, 16:40 ET Can Seeking Drug Treatment Help Your Criminal Case? | Drug Crimes Law Firm, Wichita
WICHITA, Kan., Aug. 18, 2026 /PRNewswire/ -- If you've been arrested on drug-related charges, you may be wondering whether entering a drug treatment program could help your case. It's a common question, especially for individuals whose charges are connected
More news about: McConnell Law Firm
Aug 18, 2026, 16:01 ET Halozyme Appoints Dannielle Appelhans to its Board of Directors
said Ms. Appelhans. "Halozyme has built a differentiated, royalty-driven business and a compelling strategy for durable growth through its multiple drug delivery technology platforms. I look forward to working with the board and leadership team to help deliver even greater value to patients and shareholders."Ms.
More news about: Halozyme Therapeutics, Inc.
Aug 18, 2026, 15:44 ET Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited
development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process and pharmaceutical development
More news about: Piramal Pharma Solutions
Aug 18, 2026, 15:36 ET Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited
development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process and pharmaceutical development
More news about: Piramal Pharma Solutions
Aug 18, 2026, 14:40 ET Criminal Defense Attorney Mitchell A. Stone, P.A. Explains Probation Violations in HelloNation
community, probation comes with strict court-ordered rules. These may include reporting regularly to a probation officer, avoiding new arrests, passing drug or alcohol tests, performing community service, or paying restitution. Although these conditions are designed to support rehabilitation, they also place
More news about: HelloNation
Aug 18, 2026, 12:30 ET First Person Enters Its Next Phase of Growth Following Early Think Fast™ Momentum
Claussen, and Cory Rosenberg. For more information, visit getfirstperson.com.*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.Forward-Looking StatementsThis
More news about: First Person
Aug 18, 2026, 12:15 ET SOZO® Digital Health Platform Receives FDA Clearance for Sarcopenia Risk Assessment
commercialization of medical technologies to clinically monitor and manage fluid and body composition, today announced it has received U.S. Food and Drug Administration 510(k) clearance for sarcopenia risk assessment on its SOZO® Digital Health Platform. Under the new indication, the SOZO system
More news about: ImpediMed
Aug 18, 2026, 11:06 ET Peptide Synthesis Market: USD 2.59 Billion by 2031, Driven by Therapeutic Demand & Advanced Synthesis Technologies, Says Mordor Intelligence
therapeutics, increasing pharmaceutical and biotechnology research activities, and continued advancements in peptide synthesis technologies that support drug discovery and commercial manufacturing.
More news about: Mordor Intelligence Private Limited
Aug 18, 2026, 10:33 ET Non-Metastatic Prostate Cancer Market to Exhibit Growth at a CAGR of 4% During the Forecast Period (2026-2036), as Pharmaceutical Companies Intensify Development of Advanced Therapies | DelveInsight
11.2.1Drug Description11.2.2
More news about: DelveInsight Business Research, LLP
Aug 18, 2026, 10:30 ET HYDRINITY® RetaXome Daily Retinal Hydrator Named Best Retinal in the 2026 SHAPE Beauty Awards
technologies including Supercharged HA™, MicroFusion™, and RetaXome™. Founded as a regenerative medicine company developing advanced wound care and drug delivery systems for oncology and hematology patients, HYDRINITY has since redefined dermatological skincare with clinically backed formulations featuring
More news about: HYDRINITY Accelerated Skin Science
Aug 18, 2026, 10:23 ET BreakThru SCI Launches National Advocacy Mission to Advance Promising Treatments for Spinal Cord Injury
Woodcock, M.D., former Acting Commissioner of the Food and Drug Administration (FDA), who will offer remarks at the Congressional Briefing. "This kind of constructive engagement with policymakers and regulators is essential to advancing patient-focused drug development for conditions with significant unmet need."Spinal
More news about: BreakThru SCI
Aug 18, 2026, 10:00 ET GenScript Reports 27.3% First-Half 2026 Revenue Growth as AI Drug Discovery Business Doubles
engineAI-Enabled Drug DiscoveryAI-enabled drug discovery business doubled year over year and maintained rapid growth for a third consecutive half-year reporting periodGrowth reflects deeper engagement with AI drug discovery companies and increasing
More news about: GenScript Biotech Corporation
Aug 18, 2026, 10:00 ET GenScript Reports 27.3% First-Half 2026 Revenue Growth as AI Drug Discovery Business Doubles
engineAI-Enabled Drug DiscoveryAI-enabled drug discovery business doubled year over year and maintained rapid growth for a third consecutive half-year reporting periodGrowth reflects deeper engagement with AI drug discovery companies and increasing
More news about: GenScript Biotech Corporation
Aug 18, 2026, 10:00 ET Gravity Diagnostics Names Jeff Marma Regional Sales Manager
joins Gravity Diagnostics following a 20-plus-year career at Quest Diagnostics, where he most recently served as Senior Specialty Sales Director for Drug Monitoring & Toxicology, leading a national sales team, and previously directed a national organization of more than 30 specialty sales professionals.
More news about: Gravity Diagnostics
Aug 18, 2026, 10:00 ET Parker Waichman Client Shares Story of GLP-1-Related Vision Loss with FOX Boston 25 News
or a loved one experienced sudden vision loss, blindness, or optic nerve damage after using Ozempic or Wegovy, you may have a legal claim against the drug manufacturers. Parker Waichman LLP is offering free, no-obligation case evaluations to help victims understand their rights and pursue justice.Contact
More news about: Parker Waichman LLP
Aug 18, 2026, 10:00 ET BCI Study Published in Stroke: Vascular and Interventional Neurology Confirms IpsiHand® Improves Motor Function After Stroke
print on August 13 and will be included in the October print issue of the journal.The findings establish that patients using the U.S. Food and Drug Administration (FDA)-cleared IpsiHand® System achieved significantly greater improvement in upper extremity motor function than those following
More news about: Kandu, Inc.
Aug 18, 2026, 09:17 ET ivWatch Files 510(k) with FDA for SmartTouch+™ Sensor, Expanding Continuous IV Monitoring to White-Opaque Infusates
Aug. 18, 2026 /PRNewswire/ -- ivWatch, LLC, the IV safety company, today announced it has submitted a 510(k) filing to the U.S. Food and Drug Administration (FDA) for its SmartTouch+™ Sensor, expanding the company's IV monitoring capabilities to detect infiltration and extravasation events
More news about: ivWatch, LLC
Aug 18, 2026, 09:00 ET Causaly and Syneos Health Partner to Raise the Scientific Intensity of Clinical Research
matter most in clinical development."Drug development today requires more than service providers. Syneos Health exemplifies that shift, acting as an extension of the modern biopharma enterprise and doing some of the most scientifically demanding work in drug development," said
More news about: Causaly
Aug 18, 2026, 09:00 ET J.P. Morgan Life Sciences Private Capital Welcomes Bruce N. Rogers, Ph.D. as Venture Partner
Dr. Rogers is a seasoned drug discovery and development expert with a strong track record of building innovative companies that deliver therapies across biotechnology and the pharmaceutical
More news about: J.P. Morgan Asset Management
Aug 18, 2026, 09:00 ET plusOne Partners with Snag to Bring Intimate Wellness Products Directly to College Campuses
BOSTON, Aug. 18, 2026 /PRNewswire/ -- plusOne, the leading sexual wellness brand in drug, food, and mass, today announced a new partnership with Snag, the rapidly growing delivery platform built for college campuses, naming plusOne Snag's
More news about: Beacon Wellness Brands
Aug 18, 2026, 09:00 ET Kenai Therapeutics Appoints Mark Gergen to Board of Directors
adult patients with moderate to moderate-severe idiopathic Parkinson's disease. RNDP-001 has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) in recognition of the urgent need for new treatments for Parkinson's disease. The REPLACE trial was supported in part by funding
More news about: Kenai Therapeutics/BIOCOM
Aug 18, 2026, 09:00 ET The Galien Foundation Announces 2026 International Prix Galien Award Nominees
Takashi KADOWAKIPresident of the Japanese Association of Medical SciencesJapanPr. Yeong Min PARKCEO, Korea Drug Development FundKoreaPr. Cezary SZCZYLIKPolish Professor of Medical Science Specializing in Oncology, Hematology and
More news about: The Galien Foundation